CIK 0001043961 · Non-accelerated filer<br>Smaller reporting company
Precipio, Inc.
Sign in to watch- Ticker
- PRPO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911789357
- Phone
- 203 787 7888
- Business address
- 4 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- TRANSGENOMIC INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-31 | Cossman Jeffrey Director | Returned to the company · Stock Option (Right to Buy) | −2,000 | 0 | ||
| 2024-08-31 | Cossman Jeffrey Director | Grant or award · Stock Option (Right to Buy) | +2,000 | 2,000 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −166 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +166 | 166 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −133 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +133 | 133 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −375 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +375 | 375 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −400 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +400 | 400 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −500 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +500 | 500 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −1,250 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,250 | 1,250 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2024-08-31 | Gage Matthew Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −222 | 0 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +222 | 222 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Returned to the company · Stock Option (Right to Buy) | −3,333 | 0 | ||
| 2024-08-31 | DANIELI ILAN Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +3,333 | 3,333 |
Page 9 of 11 · 211 trades